Series Preface |
|
xi | |
Acknowledgements |
|
xiii | |
|
|
1 | (10) |
|
|
|
|
10 | (1) |
|
2 Formation of fingermarks |
|
|
11 | (24) |
|
|
|
|
11 | (1) |
|
|
12 | (1) |
|
|
13 | (4) |
|
|
17 | (7) |
|
|
24 | (6) |
|
2.6 Removal of the finger from the surface |
|
|
30 | (2) |
|
2.7 Summary of the initial contact |
|
|
32 | (3) |
|
|
33 | (2) |
|
3 Composition and properties of fingermarks |
|
|
35 | (34) |
|
|
|
|
3.1 Chemical composition of fingermarks |
|
|
35 | (20) |
|
3.2 Biological properties of fingermarks |
|
|
55 | (2) |
|
3.3 Physical properties of fingermarks |
|
|
57 | (12) |
|
|
62 | (7) |
|
|
69 | (30) |
|
|
|
4.1 The `triangle of interaction' |
|
|
69 | (1) |
|
|
70 | (1) |
|
|
70 | (8) |
|
|
78 | (3) |
|
|
81 | (13) |
|
|
94 | (5) |
|
|
96 | (3) |
|
5 Initial examination and the selection of fingermark enhancement processes |
|
|
99 | (12) |
|
|
|
99 | (1) |
|
|
100 | (3) |
|
|
103 | (2) |
|
5.4 The processing environment |
|
|
105 | (6) |
|
|
109 | (2) |
|
6 Optical detection and enhancement techniques |
|
|
111 | (44) |
|
|
|
111 | (5) |
|
6.2 Current operational use |
|
|
116 | (1) |
|
|
117 | (8) |
|
6.4 Fluorescence examination |
|
|
125 | (13) |
|
6.5 Ultraviolet reflection |
|
|
138 | (3) |
|
|
141 | (3) |
|
6.7 Colour filtration and monochromatic illumination |
|
|
144 | (5) |
|
6.8 Multispectral imaging |
|
|
149 | (6) |
|
|
151 | (2) |
|
|
153 | (2) |
|
7 Vapour phase techniques |
|
|
155 | (44) |
|
|
|
|
155 | (1) |
|
7.2 Current operational use |
|
|
156 | (2) |
|
7.3 Superglue/cyanoacrylate fuming |
|
|
158 | (14) |
|
7.4 Vacuum metal deposition |
|
|
172 | (9) |
|
|
181 | (4) |
|
7.6 Radioactive sulphur dioxide |
|
|
185 | (4) |
|
7.7 Other fuming techniques |
|
|
189 | (10) |
|
|
193 | (3) |
|
|
196 | (3) |
|
8 Solid phase selective deposition techniques |
|
|
199 | (22) |
|
|
|
199 | (1) |
|
8.2 Current operational use |
|
|
200 | (1) |
|
|
201 | (12) |
|
|
213 | (3) |
|
|
216 | (5) |
|
|
219 | (2) |
|
|
221 | (54) |
|
|
|
221 | (2) |
|
9.2 Current operational use |
|
|
223 | (1) |
|
|
224 | (7) |
|
9.4 1,8-Diazafluoren-9-one |
|
|
231 | (6) |
|
|
237 | (5) |
|
|
242 | (4) |
|
|
246 | (4) |
|
|
250 | (2) |
|
|
252 | (4) |
|
|
256 | (3) |
|
|
259 | (1) |
|
9.12 4-Chloro-7-nitrobenzofuran chloride |
|
|
260 | (2) |
|
|
262 | (1) |
|
9.14 Dimethylaminocinnemaldehyde and dimethylaminobenzaldehyde |
|
|
263 | (12) |
|
|
268 | (4) |
|
|
272 | (3) |
|
10 Reagents for other eccrine constituents |
|
|
275 | (8) |
|
|
|
275 | (1) |
|
10.2 Current operational use |
|
|
276 | (1) |
|
10.3 4-Dimethylaminocinnamaldehyde |
|
|
277 | (2) |
|
|
279 | (4) |
|
|
281 | (1) |
|
|
282 | (1) |
|
|
283 | (38) |
|
|
|
283 | (2) |
|
11.2 Current operational use |
|
|
285 | (1) |
|
11.3 Solvent Black 3 (Sudan Black) |
|
|
286 | (4) |
|
11.4 Basic Violet 3 (Gentian Violet, Crystal Violet) |
|
|
290 | (5) |
|
11.5 Oil Red O (Solvent Red 27) |
|
|
295 | (2) |
|
|
297 | (2) |
|
|
299 | (2) |
|
|
301 | (1) |
|
|
302 | (3) |
|
11.10 Natural Yellow 3 (curcumin) |
|
|
305 | (3) |
|
11.11 Nile Red and Nile Blue A |
|
|
308 | (3) |
|
|
311 | (2) |
|
11.13 Rubeanic acid--copper acetate |
|
|
313 | (2) |
|
11.14 Phosphomolybdic acid |
|
|
315 | (6) |
|
|
317 | (3) |
|
|
320 | (1) |
|
12 Liquid phase selective deposition techniques |
|
|
321 | (36) |
|
|
|
321 | (2) |
|
12.2 Current operational use |
|
|
323 | (3) |
|
12.3 Small particle reagent |
|
|
326 | (4) |
|
|
330 | (6) |
|
|
336 | (9) |
|
12.6 Multi-metal deposition |
|
|
345 | (12) |
|
|
352 | (3) |
|
|
355 | (2) |
|
13 Enhancement processes for marks in blood |
|
|
357 | (26) |
|
|
|
357 | (4) |
|
13.2 Current operational use |
|
|
361 | (2) |
|
|
363 | (6) |
|
|
369 | (14) |
|
|
380 | (1) |
|
|
381 | (2) |
|
14 Electrical and electrochemical processes |
|
|
383 | (18) |
|
|
|
383 | (2) |
|
14.2 Current operational use |
|
|
385 | (1) |
|
|
386 | (2) |
|
14.4 Corrosion visualisation |
|
|
388 | (4) |
|
|
392 | (9) |
|
|
397 | (2) |
|
|
399 | (2) |
|
15 Miscellaneous processes: lifting and specialist imaging |
|
|
401 | (20) |
|
|
|
401 | (2) |
|
15.2 Current operational use |
|
|
403 | (1) |
|
|
404 | (3) |
|
15.4 Scanning electron microscopy |
|
|
407 | (3) |
|
15.5 X-ray fluorescence (and X-ray imaging) |
|
|
410 | (3) |
|
15.6 Secondary ion mass spectroscopy (SIMS) |
|
|
413 | (1) |
|
15.7 Matrix-assisted laser desorption/ionisation mass spectrometry (MALDI-MS) |
|
|
414 | (1) |
|
15.8 Attenuated total reflection Fourier transform infrared spectroscopy (ATR-FTIR) |
|
|
415 | (6) |
|
|
417 | (2) |
|
|
419 | (2) |
|
16 Evaluation and comparison of fingermark enhancement processes |
|
|
421 | (22) |
|
|
|
421 | (2) |
|
16.2 Technology Readiness Level 3: Proof of concept |
|
|
423 | (2) |
|
16.3 Technology Readiness Level 4: Process optimisation |
|
|
425 | (2) |
|
16.4 Technology Readiness Level 5: Laboratory trials |
|
|
427 | (10) |
|
16.5 Technology Readiness Level 6: Pseudo-operational trials |
|
|
437 | (2) |
|
16.6 Technology Readiness Level 7: Operational trials |
|
|
439 | (1) |
|
16.7 Technology Readiness Level 8: Standard operating procedures |
|
|
439 | (1) |
|
16.8 Technology Readiness Level 9: Ongoing monitoring |
|
|
440 | (3) |
|
|
440 | (3) |
|
17 Sequential processing and impact on other forensic evidence |
|
|
443 | (26) |
|
|
|
17.1 Sequential processing of fingermarks |
|
|
443 | (6) |
|
17.2 Test methodologies for developing processing sequences |
|
|
449 | (4) |
|
17.3 Integrated sequential forensic processing |
|
|
453 | (16) |
|
|
466 | (3) |
|
18 Interpreting the results of fingermark enhancement |
|
|
469 | (20) |
|
|
|
469 | (2) |
|
18.2 Location of the mark |
|
|
471 | (2) |
|
|
473 | (5) |
|
18.4 Constituents of the mark |
|
|
478 | (2) |
|
|
480 | (2) |
|
|
482 | (1) |
|
|
483 | (1) |
|
|
484 | (5) |
|
|
487 | (2) |
Index |
|
489 | |